FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040485426> ?p ?o ?g. }

• W2040485426 endingPage "6" @default.
• W2040485426 startingPage "1" @default.
• W2040485426 abstract "The angiotensin-converting enzyme (ACE) has two natural substrates and two catalytic domains: one cleaving angiotensin I and one inactivating bradykinin. The aim of this study was to investigate the comparative binding affinity of ACE inhibitors for the two binding sites of human endothelial ACE. In vitro binding assays were performed to test the ability of bradykinin, angiotensin I, or various ACE inhibitors (enalaprilat, perindoprilat, quinaprilat, ramiprilat, and trandolaprilat) to displace a saturating concentration of [(125)I]351A, a radiolabeled lisinopril analogue, from ACE binding sites. The calculated IC(50) values for the ACE inhibitors were in the nanomolar range, while those for the natural substrates were in the micromolar range. The bradykinin/angiotensin I selectivity ratios calculated from double displacement experiments were: perindoprilat, 1.44; ramiprilat, 1.16; quinaprilat, 1.09; trandolaprilat, 1.08; enalaprilat, 1.00. The ACE inhibitors generally had higher affinity for the bradykinin than the angiotensin I binding sites, supporting the idea that these agents are primarily inhibitors of bradykinin degradation, and secondarily inhibitors of angiotensin II production. Perindoprilat had the highest selectivity for bradykinin versus angiotensin I binding sites, and enalaprilat has the lowest. These results indicate that there are differences in the affinity of ACE inhibitors toward sites for bradykinin degradation, which could lead to differences in efficacy in cardiovascular disease." @default.
• W2040485426 created "2016-06-24" @default.
• W2040485426 creator A5021367268 @default.
• W2040485426 creator A5031764491 @default.
• W2040485426 creator A5049386321 @default.
• W2040485426 creator A5062655570 @default.
• W2040485426 creator A5067538728 @default.
• W2040485426 creator A5083460319 @default.
• W2040485426 date "2007-12-01" @default.
• W2040485426 modified "2023-10-16" @default.
• W2040485426 title "Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE" @default.
• W2040485426 cites W1516407063 @default.
• W2040485426 cites W1535139368 @default.
• W2040485426 cites W1551529449 @default.
• W2040485426 cites W1588015921 @default.
• W2040485426 cites W180946569 @default.
• W2040485426 cites W1819973517 @default.
• W2040485426 cites W1967632907 @default.
• W2040485426 cites W1987912298 @default.
• W2040485426 cites W2002907502 @default.
• W2040485426 cites W2008036316 @default.
• W2040485426 cites W2018141756 @default.
• W2040485426 cites W2020177273 @default.
• W2040485426 cites W2043635418 @default.
• W2040485426 cites W2075731388 @default.
• W2040485426 cites W2081263797 @default.
• W2040485426 cites W2088901044 @default.
• W2040485426 cites W2103565693 @default.
• W2040485426 cites W2105528815 @default.
• W2040485426 cites W2106244081 @default.
• W2040485426 cites W2116574201 @default.
• W2040485426 cites W2116631824 @default.
• W2040485426 cites W2121504382 @default.
• W2040485426 cites W2136080817 @default.
• W2040485426 cites W2157603347 @default.
• W2040485426 cites W2163942307 @default.
• W2040485426 cites W2166725046 @default.
• W2040485426 cites W2305118939 @default.
• W2040485426 cites W2313326603 @default.
• W2040485426 doi "https://doi.org/10.1016/j.ejphar.2007.07.061" @default.
• W2040485426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17716647" @default.
• W2040485426 hasPublicationYear "2007" @default.
• W2040485426 type Work @default.
• W2040485426 sameAs 2040485426 @default.
• W2040485426 citedByCount "72" @default.
• W2040485426 countsByYear W20404854262012 @default.
• W2040485426 countsByYear W20404854262013 @default.
• W2040485426 countsByYear W20404854262014 @default.
• W2040485426 countsByYear W20404854262015 @default.
• W2040485426 countsByYear W20404854262016 @default.
• W2040485426 countsByYear W20404854262017 @default.
• W2040485426 countsByYear W20404854262018 @default.
• W2040485426 countsByYear W20404854262019 @default.
• W2040485426 countsByYear W20404854262020 @default.
• W2040485426 countsByYear W20404854262021 @default.
• W2040485426 countsByYear W20404854262022 @default.
• W2040485426 countsByYear W20404854262023 @default.
• W2040485426 crossrefType "journal-article" @default.
• W2040485426 hasAuthorship W2040485426A5021367268 @default.
• W2040485426 hasAuthorship W2040485426A5031764491 @default.
• W2040485426 hasAuthorship W2040485426A5049386321 @default.
• W2040485426 hasAuthorship W2040485426A5062655570 @default.
• W2040485426 hasAuthorship W2040485426A5067538728 @default.
• W2040485426 hasAuthorship W2040485426A5083460319 @default.
• W2040485426 hasConcept C126322002 @default.
• W2040485426 hasConcept C134018914 @default.
• W2040485426 hasConcept C170493617 @default.
• W2040485426 hasConcept C181199279 @default.
• W2040485426 hasConcept C185592680 @default.
• W2040485426 hasConcept C198710026 @default.
• W2040485426 hasConcept C27016395 @default.
• W2040485426 hasConcept C2776980637 @default.
• W2040485426 hasConcept C2777814262 @default.
• W2040485426 hasConcept C2777880890 @default.
• W2040485426 hasConcept C2779591629 @default.
• W2040485426 hasConcept C2779611605 @default.
• W2040485426 hasConcept C2779888176 @default.
• W2040485426 hasConcept C2908929049 @default.
• W2040485426 hasConcept C55493867 @default.
• W2040485426 hasConcept C71924100 @default.
• W2040485426 hasConcept C84393581 @default.
• W2040485426 hasConcept C86803240 @default.
• W2040485426 hasConcept C98274493 @default.
• W2040485426 hasConceptScore W2040485426C126322002 @default.
• W2040485426 hasConceptScore W2040485426C134018914 @default.
• W2040485426 hasConceptScore W2040485426C170493617 @default.
• W2040485426 hasConceptScore W2040485426C181199279 @default.
• W2040485426 hasConceptScore W2040485426C185592680 @default.
• W2040485426 hasConceptScore W2040485426C198710026 @default.
• W2040485426 hasConceptScore W2040485426C27016395 @default.
• W2040485426 hasConceptScore W2040485426C2776980637 @default.
• W2040485426 hasConceptScore W2040485426C2777814262 @default.
• W2040485426 hasConceptScore W2040485426C2777880890 @default.
• W2040485426 hasConceptScore W2040485426C2779591629 @default.
• W2040485426 hasConceptScore W2040485426C2779611605 @default.
• W2040485426 hasConceptScore W2040485426C2779888176 @default.
• W2040485426 hasConceptScore W2040485426C2908929049 @default.
• W2040485426 hasConceptScore W2040485426C55493867 @default.

• next